TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO & Director Kirk Coleman - CFO, Treasurer & Secretary Christopher Cano - COO & VP, Business Development Bill Williams - University of Texas, Austin Dale Christensen - Head, Clinical Development Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Daniel Carlson - TW Research Yuan Zhi - B. Riley Securities Richard Deutsch - National Securities. Ted Ketterer - TK Associates Presentation Operator Good day, and welcome to the TFF Pharmaceuticals, Inc. First Quarter 2020 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Corey Davis. Please go ahead. Corey Davis Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals First Quarter Financial and Business Results Conference Call. With me on the line today is Glenn Mattes, President
For further details see:
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript